Yet, in a national Japanese survey conducted on 10 pediatric patients suffering from MKD, the use of anti-IL-1 treatment was reported in two patients [70]: In both patients, initial ANA treatment accounted for partial response, whereas a switch to CANA led to a complete response. This evidence concerns the gene IL1B and mevalonic aciduria.